Arrowhead Pharmaceuticals Inc (ARWR)
Return on assets (ROA)
| Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -599,493 | -205,275 | -176,063 | -140,848 | -84,553 |
| Total assets | US$ in thousands | 1,139,800 | 765,552 | 691,939 | 710,148 | 522,504 |
| ROA | -52.60% | -26.81% | -25.44% | -19.83% | -16.18% |
September 30, 2024 calculation
ROA = Net income ÷ Total assets
= $-599,493K ÷ $1,139,800K
= -52.60%
Arrowhead Pharmaceuticals Inc's return on assets (ROA) has shown a declining trend over the past five years, indicating a decreasing efficiency in generating profits from its assets. The ROA was -52.60% in Sep 2024, which signifies that the company experienced a net loss on its assets. This represents a significant decline compared to the previous year when the ROA was at -26.81%.
The negative ROA values suggest that Arrowhead Pharmaceuticals Inc's assets are not effectively generating profits for the company. It is important for investors and stakeholders to closely monitor the company's asset management strategies and operational efficiency to improve ROA performance in the future.
Peer comparison
Sep 30, 2024